Objective: To determine the prevalence of neurological and neuropsychiatric symptoms
reported 12 weeks (3 months) or more after acute COVID-19 onset in adults. Background …

Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system …

Background Persistent neuropsychiatric symptoms following acute COVID-19 infection are
frequently reported. These include anxiety, depression, difficulty concentrating, fatigue, and …

There is accumulating evidence of the neurological and neuropsychiatric features of
infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to …

Objective: We aimed to systematically evaluate the long-term neurological effects of COVID-
19 among recovered patients, to help in planning in the pandemic recovery phase …

The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not
established. To help inform mental health service planning in the pandemic recovery phase …

There is accumulating evidence of the neurological and neuropsychiatric features of
infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to …

Background and purpose Neurological sequelae from coronavirus disease 2019 (COVID‐
19) may persist after recovery from acute infection. Here, the aim was to describe the natural …

Introduction Post-COVID-19 syndrome is a series of chronic signs and symptoms that may
appear after SARS-CoV-2 infection, including fatigue, dyspnoea, chest pain, palpitations …

Introduction: The aim of this systematic review and meta-analysis was to evaluate the
prevalence of thirteen neurological manifestations in people affected by COVID-19 during …